Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration. [PDF]
Wolfrum P+5 more
europepmc +1 more source
REAL-WORLD LONG-TERM OUTCOMES OF INTRAVITREAL FARICIMAB IN PREVIOUSLY TREATED CHRONIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. [PDF]
Ambati NR, Leone A, Brill D, Sisk RA.
europepmc +1 more source
Short-term comparison of switching to faricimab from other anti-VEGF agents in neovascular age-related macular degeneration patients: A retrospective study. [PDF]
Liu D, Li C, Cui L, Li S.
europepmc +1 more source
Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration [PDF]
Brantley, Milam A, Jr.+4 more
core +1 more source
Correction: The I-OPTA Questionnaire: A National Assessment of Patients with Neovascular Age-Related Macular Degeneration. [PDF]
Thinggaard BS+7 more
europepmc +1 more source
Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs. [PDF]
Duncan JL+10 more
europepmc +1 more source
Optical Coherence Tomography Angiography Flow Signal in Non-Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Treated with Faricimab. [PDF]
Brinkmann M+10 more
europepmc +1 more source
Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series. [PDF]
Bantounou MA+3 more
europepmc +1 more source